348 related articles for article (PubMed ID: 25632932)
1. MicroRNAs and benign biliary tract diseases.
Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Cholangiopathies.
O'Hara SP; Gradilone SA; Masyuk TV; Tabibian JH; LaRusso NF
Curr Pathobiol Rep; 2014 Sep; 2(3):133-142. PubMed ID: 25097819
[TBL] [Abstract][Full Text] [Related]
3. [Inflammatory and neoplastic cholangiopathies.].
Alvaro D; Bragazzi MC; Ridola L
Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.
Esparza-Baquer A; Labiano I; Bujanda L; Perugorria MJ; Banales JM
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):15-27. PubMed ID: 26774196
[TBL] [Abstract][Full Text] [Related]
6. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
[TBL] [Abstract][Full Text] [Related]
7. The Cholangiopathies.
Lazaridis KN; LaRusso NF
Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in biliary diseases.
Munoz-Garrido P; García-Fernández de Barrena M; Hijona E; Carracedo M; Marín JJ; Bujanda L; Banales JM
World J Gastroenterol; 2012 Nov; 18(43):6189-96. PubMed ID: 23180938
[TBL] [Abstract][Full Text] [Related]
9. Cholangiopathies and the noncoding revolution.
Gradilone S; Brunetti-Pierri N; Piccolo P
Curr Opin Gastroenterol; 2022 Mar; 38(2):128-135. PubMed ID: 35098934
[TBL] [Abstract][Full Text] [Related]
10. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
11. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
Ahrendt SA; Rashid A; Chow JT; Eisenberger CF; Pitt HA; Sidransky D
J Hepatobiliary Pancreat Surg; 2000; 7(4):426-31. PubMed ID: 11180865
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
Chiang NJ; Shan YS; Hung WC; Chen LT
Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in the biology and diagnosis of cholangiocarcinoma.
Piontek K; Selaru FM
Semin Liver Dis; 2015 Feb; 35(1):55-62. PubMed ID: 25632935
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
Celli A; Que FG
Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
[TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
16. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and senescence in fibrosing cholangiopathies.
Nakanuma Y; Sasaki M; Harada K
J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
[TBL] [Abstract][Full Text] [Related]
18. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
19. Biliary differentiation and bile duct morphogenesis in development and disease.
Raynaud P; Carpentier R; Antoniou A; Lemaigre FP
Int J Biochem Cell Biol; 2011 Feb; 43(2):245-56. PubMed ID: 19735739
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
Erice O; Munoz-Garrido P; Vaquero J; Perugorria MJ; Fernandez-Barrena MG; Saez E; Santos-Laso A; Arbelaiz A; Jimenez-Agüero R; Fernandez-Irigoyen J; Santamaria E; Torrano V; Carracedo A; Ananthanarayanan M; Marzioni M; Prieto J; Beuers U; Oude Elferink RP; LaRusso NF; Bujanda L; Marin JJG; Banales JM
Hepatology; 2018 Apr; 67(4):1420-1440. PubMed ID: 28922472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
